Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 10, 2024, titled "Strides receives USFDA approval for Sevelamer Carbonate Tablets, 800 mg".
Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 10, 2024, titled "Strides receives USFDA approval for Sevelamer Carbonate Tablets, 800 mg".